Laurus Labs inks pact with MPP to manufacture molnupiravir Medical Dialogues Bureau22 Jan 2022 3:52 PM ISTNew Delhi: Drug firm Laurus Labs on Friday said it has inked a pact with Geneva-based MPP (Medicine Patient Pool) for manufacturing the oral COVID-19...
Aurobindo Pharma launches COVID-19 drug Molnupiravir Medical Dialogues Bureau7 Jan 2022 9:00 AM ISTHYDERABAD: Aurobindo Pharma Limited has launched COVID-19 treatment drug Molnupiravir under brand name "Molnaflu" in India.Molnupiravir is for...
COVID: Optimus Pharma submits phase 3 trials interim result for Molnupiravir capsules Ruchika Sharma22 July 2021 2:00 PM ISTOptimus has approached DCGI to seek Emergency Use Authorization for Molnupiravir in India, the release said.
MSN Labs begins COVID drug Molnupiravir phase III trial Ruchika Sharma26 May 2021 12:23 PM ISTMolnupiravir is an experimental drug having antiviral properties and is currently under clinical-stage study for COVID treatment.
COVID-19: Natco Pharma begins Molnupiravir capsules Phase III trial in India Ruchika Sharma23 May 2021 9:45 AM ISTHyderabad: Drug major, Natco Pharma Limited, has initiated Phase-III clinical trial of Molnupiravir capsules in India. Its first patient was...
Natco Pharma seeks CDSCO emergency nod for Covid drug Molnupiravir Ruchika Sharma27 April 2021 12:27 PM ISTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company has applied to the Central Drugs Standard Control...
